Wan Seok Yang

Title: Innovations by Wan Seok Yang

Introduction

Wan Seok Yang is an accomplished inventor based in New York, NY (US). She has made significant contributions to the field of cancer research through her innovative patents. With a total of 3 patents, her work focuses on developing compounds that target oncogenic RAS mutations.

Latest Patents

One of her latest patents is titled "Carbonyl erastin analogs and their use." This invention provides compounds with a specific structure that can be used in compositions for treating cancers associated with oncogenic RAS mutations. The methods outlined in this patent also include modulating lipoxygenase in the ferroptosis cell death pathway and depleting reduced glutathione (GSH) in affected cells.

Another notable patent is "Quinazolinone-based oncogenic-RAS-selective lethal compounds and their use." Similar to her previous work, this invention offers compounds that can be utilized in compositions for treating cancers linked to oncogenic RAS mutations. The methods described also focus on modulating lipoxygenase and depleting GSH in relevant cells.

Career Highlights

Wan Seok Yang is affiliated with Columbia University, where she continues her research and development efforts. Her work has garnered attention for its potential impact on cancer treatment and therapy.

Collaborations

She collaborates with notable colleagues, including Brent R. Stockwell and Matthew Welsch, enhancing the scope and depth of her research.

Conclusion

Wan Seok Yang's innovative contributions to cancer research through her patents demonstrate her commitment to advancing medical science. Her work holds promise for improving treatment options for patients with specific cancer types.